Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma

Fig. 3

WDFY3-AS2 expression in stratified patients. a WDFY3-AS2 expression among different pathologic grades. b WDFY3-AS2 expression among different subtypes of patients. c WDFY3-AS2 expression between MGMT promoter methylated and unmethylated patients. d WDFY3-AS2 expression between LGG IDH-mut and IDH-wt patients. e WDFY3-AS2 expression between GBM IDH-mut and IDH-wt patients

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us